“…Large bone defects resulting from trauma, degenerative diseases, tumors, etc. have long been a vital clinical threat to human health. , Despite their widespread use, autologous and allogeneic bone grafts suffer from drawbacks, such as sacrificial bone donor sites, insufficient supply, and other surgical complications. − Three-dimensional (3D) printing, also known as additive manufacturing, is an innovative technique for boosting the development of bone tissue engineering, − because it can meet the clinical needs for personalized design and spatial porous constructs. , Among the available material choices, biodegradable polymers are identified as a preferred candidate due to their excellent biocompatibility, suitable mechanical properties, and good processability. , Numerous clinically approved biodegradable polymers, such as polycaprolactone (PCL), poly(lactic acid) (PLA), and poly(lactides- co -glycolides) (PLGA), etc., have been employed as the matrices to produce 3D-printed scaffolds. ,− Unfortunately, the bioinert nature of these biodegradable polymers results in insufficient biofunctions, hindering cellular activities and bone regeneration. , Thus, endowing 3D-printed scaffolds with osteoconductivity and osteogenesis is highly required to ensure their orthopedic applications.…”